glp 1 probiotic pendulum Glucose Control Pendulum GLP Pendulum GLP-1 Probiotic Pro -
Description
The SURMOUNT-1 trial for tirzepatide showed average weight loss of 15 to 22 percent of body weight across the full study population
Theres no one size fits all
However, up to 89% of participants taking efinopegdutide experienced gastrointestinal adverse events (mostly nausea, vomiting and diarrhoea) relative to 28% taking placebo and 60% taking liraglutide (86)
They are not intended to treat, manage, or replace medical care
Different Formulations: Some medications come in different forms, such as daily or weekly injections, which might be more convenient for you
